Rep. Angie Craig

Maddy summaryHR 3419 reauthorizes and increases mandatory funding for U.S. animal disease prevention programs through fiscal year 2028. It allocates $233 million annually from the Commodity Credit Corporation for three key areas: $10 million for disease prevention, $70 million for surveillance, and $153 million for rapid response. The bill also raises annual funding for the National Animal Health Laboratory from $30 million to $45 million. These provisions directly affect USDA programs that protect livestock and agricultural industries from foreign animal disease outbreaks. The funding increases extend existing programs through 2028, with reduced annual amounts starting in 2029.

Maddy summaryThis bill improves the VA Work-Study program for veterans and active-duty military members by expanding eligible work opportunities to include roles with state/local governments and nonprofits that support veterans. It establishes a higher minimum wage standard, requiring payments to meet the highest of federal, state, or local minimum wage rates. The bill also requires electronic time tracking for participants and annual public reporting on program data, including participant demographics, wages, hours worked, and participating schools. These changes apply to work-study payments made on or after January 1, 2026.

Maddy summaryThe Equality Act (HR 15) would amend federal civil rights laws to explicitly prohibit discrimination based on sexual orientation and gender identity in public accommodations, housing, employment, credit, and jury service. It amends the Civil Rights Act of 1964 to include sexual orientation and gender identity as protected characteristics under existing sex discrimination provisions. The bill would require businesses, housing providers, employers, and government entities to provide equal access and services without regard to a person's sexual orientation or gender identity. It includes specific definitions for gender identity and sexual orientation to clarify protections across all covered areas. The law would apply to all entities covered by the Civil Rights Act of 1964, including those receiving federal funding.

Maddy summaryThis bill expands benefits for National Guard members injured during state duty. It allows members to qualify for military retirement pay based on disabilities incurred while performing "State active duty" (e.g., responding to natural disasters under state governor authority), not just federal deployments. It also creates a new VA health care program covering treatment for disabilities from state duty, with limits: VA care is only provided after exhausting other insurance claims and subject to annual funding. These changes directly affect National Guard members injured during state missions, ensuring they can access retirement pay and VA medical care without duplicating existing federal or state disability benefits.

Maddy summaryHR 4121, the Right to Contraception Act, establishes a federal statutory right for individuals to access contraceptives and contraception services without government restriction or coercion, directly affecting all people seeking reproductive care and health care providers. The bill prohibits state or federal laws that limit access to contraceptives (defined broadly to include devices, drugs, and fertility methods), prevent individuals from obtaining or using them, or allow providers to refuse services based on personal beliefs. It preempts conflicting state laws, requires any restrictions to be justified by "clear and convincing evidence" of advancing access with no less restrictive alternative, and allows private lawsuits to challenge violations. The Act applies nationwide to all health care providers and individuals, protecting access regardless of factors like race, income, or location.

Maddy summaryThis bill updates opioid prevention funding by specifically naming the fentanyl crisis in grant program language and increases annual funding. It amends the Public Health Service Act to include "such as the fentanyl crisis" when describing eligible public health crises for prevention grants, and raises authorized funding from $496 million (2019-2023) to $505.579 million annually (2024-2028). The changes directly affect federal opioid prevention grant programs administered by health agencies, ensuring funding aligns with current overdose challenges. The bill focuses on maintaining and expanding existing prevention efforts through updated language and increased financial support.

Maddy summaryHR 4076 establishes a joint U.S.-Israel program to fund health technology development, authorizing $4 million annually (2024-2026) through the U.S. Health and Human Services Department. It requires Israel to match U.S. funding and focuses on collaborative projects in artificial intelligence, vaccines, telemedicine, diagnostic tests, and data-driven personalized medicine for emerging infectious diseases. The program can either build on an existing U.S.-Israel agreement or create a new one under a 2008 science cooperation framework. This bill directly affects U.S. federal health agencies and the Israeli government, with funds restricted to joint projects meeting specific technological and health priorities.

Maddy summaryThis bill increases annual funding for the Substance Use Disorder Treatment Workforce Loan Repayment Program from $25 million to $40 million per year, covering fiscal years 2024 through 2028. It directly affects healthcare professionals working in substance use disorder treatment who have federal student loans, helping them repay those loans through federal reimbursement. The key provision is the funding increase, extending the program's support for this workforce without altering eligibility or new requirements. This change provides more consistent financial support for treatment providers, aiming to address staffing needs in a critical healthcare area.

Naloxone Affordability Act of 2023 This bill requires the Government Accountability Office to study access to and affordability of naloxone (a medication that temporarily reverses opioid overdoses). The study must address matters related to out-of-pocket costs that consumers pay for naloxone and coverage for naloxone as an over-the-counter drug through Medicare, Medicaid, and private health insurance. Historically, naloxone required a prescription and so was typically covered by health insurance. However, the Food and Drug Administration approved Narcan (a naloxone hydrochloride nasal spray) for use without a prescription on March 29, 2023, and health insurance does not generally cover over-the-counter medications.

Maddy summaryThe American Dream and Promise Act of 2023 would create two pathways to permanent residency for certain immigrants. The "Dream Act" portion would provide conditional permanent resident status to individuals who entered the U.S. as children, have lived continuously in the U.S. since January 1, 2021, and meet educational requirements (such as completing high school, earning a degree, or enrolling in education programs). The "American Promise Act" portion would provide permanent residency to individuals eligible for Temporary Protected Status (TPS) or Deferred Enforced Departure (DED) as of specific dates (January 1, 2017, or January 20, 2021). The bill includes provisions for background checks, fee exemptions for low-income applicants, and processes for removing conditional status after meeting specific criteria like completing higher education or earning income.